Effect of Anti-Cytokine Treatment on the Success Rate of Vital Pulp Therapy Anti-cytokine Therapy in Vital Pulp Treatment
Regeneration, Reconstruction & Restoration (Triple R),
Vol. 9 (2024),
1 January 2024
https://doi.org/10.22037/rrr.v9.46854
Abstract
Human dental pulp is a unique connective tissue able to respond to the invasion of pathogens and their by-products in the root canal system via inflammatory reactions in order to remove etiological factors and encourage healing; resulting in “Pulpitis”, which is namely defined by the accumulation of inflammatory mediators, specifically pro-inflammatory cytokines and chemokines. However, if the inflammation progresses and pathogens are not appropriately reduced or eliminated, pulp necrosis will ultimately occur; causing the need for radical pulpectomy and consequently, loss of tooth vitality. Vital pulp therapy (VPT), as a concrete example of regenerative endodontics, is based upon minimally invasive concept; in which the conservation of compromised or inflamed dental pulpal tissue is of critical importance for dentine-pulp regeneration. Pro-inflammatory cytokines, as host modulators, play a significant role in the amendment of intensity and duration of immune response to pathogenic factors. Since the modulation of inflammation is crucial in reaching successful outcomes in VPT, anti-cytokine therapy may assist in achieving the aforementioned results. In addition, when the amount of pro-inflammatory cytokines increases, the pulpal inflammation seems to escalate and negatively affect the tissue healing. Therefore, if cytokines are modulated, the inflammatory process can be favourably controlled, and the healing of dental pulp tissue may be promoted.
- Cytokines
- Endodontics
- Inflammation
- Regenerative Endodontic Procedures
- Vital pulp therapy
How to Cite
References
Joseph A, Nalini H, Kumar A, Devi R. Pharmacotherapy for host modulation in periodontal disease: A review. J Indian Acad Dent Spec Res. 2015;2:35.
Ipshita S, Kurian IG, Dileep P, Guruprasad C, Singh P, Pradeep A. Host modulation therapy: An updated review. J adv clin res insights. 2017;4(2):55-8.
Kamil MA. Host modulatory agents in periodontics the valuable innovation. J Dent Med Sci. 2016;15(6):105-11.
Shinwari MS, Tanwir F, Hyder PR, Bin Saeed MH. Host modulation therapeutics in periodontics: role as an adjunctive periodontal therapy. J Coll Physicians Surg Pak. 2014;24(9):676-84.
Lotti T, Hercogova J. Successful treatment of psoriasis with low-dose per os interleukins 4, 10, and 11. Dermatol Ther. 2015;28(1):1-2.
Arora S, Cooper P, Friedlander L, Rizwan S, Seo B, Rich A, et al. Potential application of immunotherapy for modulation of pulp inflammation: Opportunities for vital pulp treatment. Int Endod J. 2021;54(8):1263-74.
Eng GP, Bouchelouche P, Bartels EM, Bliddal H, Bendtzen K, Stoltenberg M. Anti-drug antibodies, drug levels, interleukin-6 and soluble TNF receptors in rheumatoid arthritis patients during the first 6 months of treatment with adalimumab or infliximab: a descriptive cohort study. PloS one. 2016;11(9):e0162316.
Preshaw PM. Host modulation therapy with anti‐inflammatory agents. Periodontol 2000. 2018;76(1):131-49.
Jangid K, Ramamurthy J, Mathew V, Jayakumar N. Anti-cytokine therapy in periodontitis. Res J Pharm Biol Chem Sci. 2015;6(1):372-6.
Patil A, Mahale S. Cytokines and anti-cytokine therapy in periodontal disease. J Med Dent Sci. 2017;16(3):63-70.
Assuma R, Oates T, Cochran D, Amar S, Graves D. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol Res. 1998;160(1):403-9.
Delima AJ, Karatzas S, Amar S, Graves DT. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis. 2002;186(4):511-6.
Sulijaya B, Takahashi N, Yamazaki K. Host modulation therapy using anti-inflammatory and antioxidant agents in periodontitis: a review to a clinical translation. Arch Oral Biol. 2019;105:72-80.
Khorasani MM, Hassanshahi G, Brodzikowska A, Khorramdelazad H. Role(s) of cytokines in pulpitis: latest evidence and therapeutic approaches. Cytokine. 2020;126(2):154896.
Rechenberg D-K, Galicia JC, Peters OA. Biological markers for pulpal inflammation: a systematic review. PloS one. 2016;11(11):e0167289.
Zanini M, Meyer E, Simon S. Pulp inflammation diagnosis from clinical to inflammatory mediators: a systematic review. J Endod. 2017;43(7):1033-51.
Komabayashi T, Zhu Q. Innovative endodontic therapy for anti-inflammatory direct pulp capping of permanent teeth with a mature apex. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(5):e75-e81.
Santos JM, Pereira JF, Marques A, Sequeira DB, Friedman S. Vital pulp therapy in permanent mature posterior teeth with symptomatic irreversible pulpitis: a systematic review of treatment outcomes. Medicina. 2021;57(6):573.
Parhizkar A, Asgary S. Local Drug Delivery Systems for Vital Pulp Therapy: A New Hope. International Journal of Biomaterials. 2021;2021:5584268.
Taha NA, About I, Sedgley CM, Messer HH. Conservative management of mature permanent teeth with carious pulp exposure. J Endod. 2020;46(9):S33-S41.
Li J-Y, Wang S-N, Dong Y-M. The effect of topical application of meloxicam on inflamed dental pulp. J Dent Sci. 2021;16(3):915-21.
Chen J, Xu H, Xia K, Cheng S, Zhang Q. Resolvin E1 accelerates pulp repair by regulating inflammation and stimulating dentin regeneration in dental pulp stem cells. Stem Cell Res Ther. 2021;12(1):1-14.
Koli B, Chawla A, Logani A, Kumar V, Sharma S. Combination of nonsurgical endodontic and vital pulp therapy for management of mature permanent mandibular molar teeth with symptomatic irreversible pulpitis and apical periodontitis. J Endod. 2021;47(3):374-81.
Kermeoğlu F, Aksoy U, Sebai A, Savtekin G, Özkayalar H, Sayıner S, et al. Anti-inflammatory effects of melatonin and 5-methoxytryptophol on lipopolysaccharide-induced acute pulpitis in rats. Biomed Res Int. 2021;6:1-8.
Dincer GA, Erdemir A, Kisa U. Comparison of neurokinin A, substance P, interleukin 8, and matrix metalloproteinase-8 changes in pulp tissue and gingival crevicular fluid samples of healthy and symptomatic irreversible pulpitis teeth. J Endod. 2020;46(10):1428-37.
Nguyen V, Chen Y-W, Johnson JD, Paranjpe A. In vivo evaluation of effect of preoperative ibuprofen on proinflammatory mediators in irreversible pulpitis cases. J Endod. 2020;46(9):1210-6.
Šubarić L, Mitić A, Matvijenko V, Jovanović R, Živković D, Perić D, et al. Interleukin 1-beta analysis in chronically inflamed and healthy human dental pulp. Vojnosanit Pregl. 2017;74(3):256-60.
Kritikou K, Imre M, Tanase M, Vinereanu A, Totan AR, Spinu T-C, et al. Biochemical mapping of the inflamed human dental pulp. Appl Sci. 2021;11(21):10395.
Giuroiu CL, Vataman M, Melian G, Bularda D, Lozneanu L, Salceanu M, et al. Detection and assessment of interleukin 6 in irreversible pulp inflammation. Rev Chim. 2017;68(2):323-7.
Yang F, Zhang X, Huang H, Wu G, Lippuner K, Hunziker EB. Anticytokine activity enhances osteogenesis of bioactive implants. Tissue Eng Part A. 2021;27(3-4):177-86.
Giraud T, Jeanneau C, Rombouts C, Bakhtiar H, Laurent P, About I. Pulp capping materials modulate the balance between inflammation and regeneration. Dent Mater. 2019;35(1):24-35.
Zaky S, Shehabeldin M, Ray H, Sfeir C. The role of inflammation modulation in dental pulp regeneration. Eur Cell Mater. 2021;41:184-93.
Shima Y. Cytokines involved in the pathogenesis of SSc and problems in the development of anti-cytokine therapy. Cells. 2021;10(5):1104.
Fabri GMC, Pereira RMR, Savioli C, Saad CG, de Moraes JCB, Siqueira JTT, et al. Periodontitis response to anti-TNF therapy in ankylosing spondylitis. J Clin Rheumatol. 2015;21(7):341-5.
Rallis KS, Corrigan AE, Dadah H, George AM, Keshwara SM, Sideris M, et al. Cytokine-based cancer immunotherapy: Challenges and opportunities for IL-10. Anticancer Res. 2021;41(7):3247-52.
Liu M, Zhao Y, Wang C, Luo H, Peng A, Ye L. Interleukin-17 plays a role in pulp inflammation partly by WNT5A protein induction. Arch Oral Biol. 2019;103:33-9.
Elsalhy M, Azizieh F, Raghupathy R. Cytokines as diagnostic markers of pulpal inflammation. Int Endod J. 2013;46(6):573-80.
Louwakul P, Lertchirakarn V. Response of inflamed pulps of rat molars after capping with pulp-capping material containing fluocinolone acetonide. J Endod. 2015;41(4):508-12.
Parhizkar A, Nojehdehian H, Tabatabaei F, Asgary S. An Innovative Drug Delivery System Loaded with a Modified Combination of Triple Antibiotics for Use in Endodontic Applications. International Journal of Dentistry. 2020;2020:8859566.
Lin LM, Ricucci D, Saoud TM, Sigurdsson A, Kahler B. Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology. Aust Endod J. 2020;46(1):154-66.
- Abstract Viewed: 55 times
- PDF Downloaded: 15 times